Paul Sax, MD, FIDSA, is joined by Varun Phadke, MD, and Daniel Minter, MD, co-creators of CID’s new series, “Clinical Dilemmas in Infectious Diseases,” which guides readers through challenging clinical management decisions in infectious diseases.
Lifesaving treatment and prevention programs for tuberculosis, malaria, H.I.V. and other diseases cannot access funds to continue work.
Lifesaving treatment and prevention programs for tuberculosis, malaria, H.I.V. and other diseases cannot access funds to continue work.
Papers may be submitted in the following categories. The editors reserve the right to change the category for consistency with CID style. Major Articles Brie
On 30 January 2025, the Ministry of Health of Uganda declared an outbreak of Sudan virus disease (SVD) following confirmation from three national reference laboratories.…
Aides to Elon Musk charged with running the U.S. government human resources agency have locked career civil servants out of computer systems that contain the…
Weekly overview of respiratory virus data submitted by laboratories across Canada.
We are independent and ultimately accountable to people living with and affected by HIV. We weigh and measure our actions against their impact on people’s…
Kansas is experiencing the largest tuberculosis outbreak in decades, with 60 active cases in Wyandotte County and 7 in Johnson County, while health authorities work…
The IAS supports the growth of a new generation of HIV researchers, advocates and healthcare professionals in regions where resources for HIV are limited. Fellowship…
